Continuous Bioprocessing Market
完整報告名稱與涵蓋範圍
Continuous Bioprocessing Market Size, Share & Trends Analysis Report, By Product (Upstream Systems (Perfusion Bioreactors and Cell Retention Devices), Downstream Systems (Continuous Chromatography, Viral Inactivation and Filtration), Single-Use Consumables and Sensors, Process Analytical Technology and Control Software), By Process Type (Continuous Upstream Only, Continuous Downstream Only, Integrated End-to-End Continuous Processing), By Application (Monoclonal Antibodies and Recombinant Proteins, Vaccines and Viral Vectors, Cell and Gene Therapy and Other Biologics), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The continuous bioprocessing market covers upstream perfusion systems and cell retention devices, continuous downstream equipment such as multi-column chromatography and continuous viral inactivation, the single-use consumables and sensors they require and the process analytical technology and control software that links operations, applied to antibodies, recombinant proteins, vaccines, viral vectors and other biologics. Conventional fed-batch equipment and stainless-steel facilities are excluded except where retrofitted for continuous operation.
Manufacturers are intensifying processes to raise productivity per litre, shrink facility footprints and respond to cost pressure from biosimilars and to demand surges for specific products. Perfusion and high-density seed trains are already widely used, continuous capture chromatography has moved from pilot to commercial use at several companies, and integrated end-to-end continuous lines are being validated for commercial supply. Enablers include robust single-use perfusion devices, in-line analytics, automation that manages steady-state operation over weeks and regulatory guidance on continuous manufacturing that clarifies batch definition and control strategy. Barriers include validation complexity, workforce skills and the inertia of existing batch facilities.
North America and Europe lead adoption, and South Korea, China and Singapore are installing intensified capacity in new CDMO and biosimilar plants. Competition involves bioprocess equipment leaders, filtration and chromatography specialists and biologics manufacturers developing proprietary continuous platforms.
The InsightAce study delivers revenue forecasts in US$ across all product, process type, application and end user and regional segments for 2026-2035, alongside segment-level trend analysis, competitive landscape assessment and detailed company profiling.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Continuous Bioprocessing Market Snapshot
Chapter 4. Global Continuous Bioprocessing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. Product & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product:
5.2.1. Upstream Systems (Perfusion Bioreactors and Cell Retention Devices)
5.2.2. Downstream Systems (Continuous Chromatography, Viral Inactivation and Filtration)
5.2.3. Single-Use Consumables and Sensors
5.2.4. Process Analytical Technology and Control Software
Chapter 6. Market Segmentation 2: By Process Type Estimates & Trend Analysis
6.1. Process Type & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Process Type:
6.2.1. Continuous Upstream Only
6.2.2. Continuous Downstream Only
6.2.3. Integrated End-to-End Continuous Processing
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. Monoclonal Antibodies and Recombinant Proteins
7.2.2. Vaccines and Viral Vectors
7.2.3. Cell and Gene Therapy and Other Biologics
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Biopharmaceutical Manufacturers
8.2.2. CDMOs
8.2.3. Academic and Research Institutes
Chapter 9. Continuous Bioprocessing Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Sartorius AG
11.2. Cytiva (Danaher)
11.3. Repligen Corporation
11.4. Thermo Fisher Scientific Inc.
11.5. Merck KGaA (MilliporeSigma)
11.6. Pall Corporation (Danaher)
11.7. Asahi Kasei Bioprocess
11.8. 3M Company (Solventum Separation Technologies)
11.9. Bio-Rad Laboratories, Inc.
11.10. Eppendorf SE
11.11. Univercells Technologies
11.12. Boehringer Ingelheim International GmbH
11.13. WuXi Biologics (Cayman) Inc.
11.14. Samsung Biologics Co., Ltd.
11.15. Bionet (Getinge)
圖表清單 List of Tables & Figures
Table 1. Global Continuous Bioprocessing Revenue Forecast by Product, 2026-2035 (US$ Mn)
Figure 1. Global Continuous Bioprocessing Market Snapshot, 2026 & 2035
Table 2. Global Continuous Bioprocessing Revenue Forecast by Process Type, 2026-2035 (US$ Mn)
Figure 2. Global Continuous Bioprocessing Market Share by Process Type, 2026 & 2035
Table 3. Global Continuous Bioprocessing Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. Fed-Batch, Intensified and End-to-End Continuous Processing: Productivity and Footprint Comparison
Table 4. Global Continuous Bioprocessing Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Adoption of Continuous Unit Operations Across Biologics Manufacturers, 2026-2035
Table 5. North America Continuous Bioprocessing Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Continuous Bioprocessing Growth Opportunity Analysis
Table 6. Europe Continuous Bioprocessing Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Regulatory Guidance and Control Strategy Requirements for Continuous Manufacturing
Table 7. Asia Pacific Continuous Bioprocessing Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Competitive Positioning of Key Continuous Bioprocessing Market Participants
Table 8. Latin America and Middle East & Africa Continuous Bioprocessing Revenue Forecast, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們